Chemring Group PLC
CMGMY · OTC
10/31/2025 | 10/31/2024 | 10/31/2023 | 10/31/2022 | |
|---|---|---|---|---|
| Revenue | $498 | $510 | $473 | $401 |
| % Growth | -2.5% | 8% | 17.9% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $498 | $510 | $473 | $401 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $0 | $0 | $131 | $82 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $5 | $7 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $424 | $452 | $291 | $264 |
| Operating Expenses | $424 | $452 | $427 | $352 |
| Operating Income | $96 | $58 | $45 | $49 |
| % Margin | 19.3% | 11.4% | 9.6% | 12.3% |
| Other Income/Exp. Net | -$6 | -$5 | -$1 | -$2 |
| Pre-Tax Income | $68 | $53 | $44 | $48 |
| Tax Expense | $19 | $11 | $6 | $4 |
| Net Income | $48 | $40 | $5 | $47 |
| % Margin | 9.7% | 7.7% | 1.1% | 11.8% |
| EPS | 0.23 | 0.16 | 0.019 | 0.17 |
| % Growth | 43.8% | 733.3% | -88.7% | – |
| EPS Diluted | 0.23 | 0.14 | 0.019 | 0.15 |
| Weighted Avg Shares Out | 271 | 273 | 282 | 281 |
| Weighted Avg Shares Out Dil | 276 | 279 | 289 | 288 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $1 | $1 |
| Interest Expense | $7 | $0 | $4 | $2 |
| Depreciation & Amortization | $27 | $25 | $22 | $22 |
| EBITDA | $100 | $83 | $68 | $71 |
| % Margin | 20.1% | 16.2% | 14.3% | 17.8% |